AAA August 2015 – Page 13

LifeBond fastens $27m to series D

Israel-based surgical glue developer LifeBond closed its series D round at $27m yesterday after raising additional capital from pharmaceutical company investors including pharmaceutical company Sino Biopharmaceutical. The round also included healthcare company Johnson & Johnson, Giza Venture Capital, Aurum Ventures, Pitango Venture Capital, GlenRock Israel and Zitelman Group and Adams Street Partners. Johnson & Johnson… Continue reading LifeBond fastens $27m to series D